Arnogene: A Phosphocalcic Study in Dialysis

Searching for high morbi-mortality risk Klotho variants in dialysis patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dialysis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Edouard Herriot

Lyon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Every adult > 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.

Treatment and study plan

blood sample

Genetic

Searching for Klotho variants in DNA

Primary outcomes

Assessing morbi-mortality based on Klotho variants

Secondary outcomes

Survival and serum phosphocalcic parameters

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients

Acronym: ARNOGENE

Important dates

Study start: 2008
Study completion: 2009
First posted: Mar 9, 2009
Registry last updated: Sep 4, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed